Mitra Ranjbar

804 total citations
31 papers, 571 citations indexed

About

Mitra Ranjbar is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Mitra Ranjbar has authored 31 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 12 papers in Infectious Diseases and 8 papers in Hepatology. Recurrent topics in Mitra Ranjbar's work include Hepatitis B Virus Studies (9 papers), COVID-19 Clinical Research Studies (8 papers) and Hepatitis C virus research (7 papers). Mitra Ranjbar is often cited by papers focused on Hepatitis B Virus Studies (9 papers), COVID-19 Clinical Research Studies (8 papers) and Hepatitis C virus research (7 papers). Mitra Ranjbar collaborates with scholars based in Iran, United Kingdom and United States. Mitra Ranjbar's co-authors include Hossein Keyvani, Fariba Keramat, Seyyed Hamid Hashemi, Marzieh Nojomi, Mojgan Mamani, Seyed Moayed Alavian, Amir Houshang Mohammad Alizadeh, Zeynab Yassin, Ali Rahimi and Hossein Khorramdelazad and has published in prestigious journals such as World Journal of Gastroenterology, International Immunopharmacology and BMC Infectious Diseases.

In The Last Decade

Mitra Ranjbar

29 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitra Ranjbar Iran 13 297 182 152 124 63 31 571
Kenan Hızel Türkiye 15 245 0.8× 237 1.3× 43 0.3× 63 0.5× 65 1.0× 46 554
Nurgül Ceran Türkiye 15 239 0.8× 142 0.8× 43 0.3× 90 0.7× 9 0.1× 28 503
Ferhat Arslan Türkiye 12 212 0.7× 132 0.7× 76 0.5× 26 0.2× 11 0.2× 60 539
Carlos Fritzsche Germany 14 218 0.7× 217 1.2× 63 0.4× 13 0.1× 13 0.2× 39 452
Canan Külah Türkiye 16 174 0.6× 185 1.0× 36 0.2× 35 0.3× 13 0.2× 37 582
Shariq Haider Canada 12 456 1.5× 479 2.6× 23 0.2× 42 0.3× 25 0.4× 30 692
Can Polat Eyigün Türkiye 11 160 0.5× 47 0.3× 60 0.4× 80 0.6× 4 0.1× 54 313
Gülsüm İclal Bayhan Türkiye 12 96 0.3× 131 0.7× 14 0.1× 44 0.4× 13 0.2× 93 380
Rungmei S. K. Marak India 11 460 1.5× 660 3.6× 15 0.1× 33 0.3× 52 0.8× 40 839
Robert E. Levitz United States 10 255 0.9× 113 0.6× 80 0.5× 5 0.0× 26 0.4× 15 440

Countries citing papers authored by Mitra Ranjbar

Since Specialization
Citations

This map shows the geographic impact of Mitra Ranjbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitra Ranjbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitra Ranjbar more than expected).

Fields of papers citing papers by Mitra Ranjbar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitra Ranjbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitra Ranjbar. The network helps show where Mitra Ranjbar may publish in the future.

Co-authorship network of co-authors of Mitra Ranjbar

This figure shows the co-authorship network connecting the top 25 collaborators of Mitra Ranjbar. A scholar is included among the top collaborators of Mitra Ranjbar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitra Ranjbar. Mitra Ranjbar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Abdollahi, Arash, Marzieh Nojomi, Yeganeh Karimi, & Mitra Ranjbar. (2024). Mortality patterns in patients with Staphylococcus aureus bacteremia during the COVID-19 pandemic: Predictors and insights. Heliyon. 10(2). e24511–e24511. 3 indexed citations
3.
Naghizadeh, Mohammad Mehdi, et al.. (2023). Effect of tofacitinib on clinical and laboratory findings in severe and resistant patients with COVID-19. International Immunopharmacology. 122. 110565–110565. 4 indexed citations
4.
Tameshkel, Fahimeh Safarnezhad, Alireza Tabibzadeh, Mitra Ranjbar, et al.. (2023). A Retrospective Study on the Gam-COVID-Vac (Sputnik V) COVID-19 Vaccine Short-Term Efficacy and Side Effects in Iranian Healthcare Providers. Archives of Clinical Infectious Diseases. 18(3).
5.
Kalantari, Saeed, et al.. (2023). The effect of oral probiotics on CD4 count in patients with HIV infection undergoing treatment with ART who have had an immunological failure. Immunity Inflammation and Disease. 11(6). e913–e913. 10 indexed citations
6.
Ranjbar, Mitra, et al.. (2022). Role of CCL2/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table. International Immunopharmacology. 113(Pt A). 109325–109325. 39 indexed citations
7.
Moradi, Yousef, et al.. (2022). Nonsteroidal anti‐inflammatory drugs in acute viral respiratory tract infections: An updated systematic review. Pharmacology Research & Perspectives. 10(2). e00925–e00925. 12 indexed citations
8.
Ranjbar, Mitra, et al.. (2020). Efficacy and safety of chloroquine and hydroxychloroquine for COVID-19: A comprehensive evidence synthesis of clinical, animal, and in vitro studies. Medical Journal of the Islamic Republic of Iran. 34. 171–171. 1 indexed citations
9.
Nojomi, Marzieh, et al.. (2020). Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial. BMC Infectious Diseases. 20(1). 954–954. 127 indexed citations
10.
Meamar, Ahmad Reza, et al.. (2018). Investigating the Prevalence of Enteric Opportunistic Parasitic Infections among Cancer Patients of a Teaching Hospital. 7(1). 12–22. 7 indexed citations
11.
Ranjbar, Mitra, et al.. (2017). Occult Hepatitis C Infection Among Hemodialysis Patients: A Prevalence Study. Annals of Hepatology. 16(4). 510–513. 19 indexed citations
12.
Ranjbar, Mitra, et al.. (2012). Nosocomial infections and antimicrobial resistance pattern in a tertiary referral hospital in Hamedan, Iran. International Journal of Critical Illness and Injury Science. 2(1). 46–46. 3 indexed citations
13.
Alizadeh, Amir Houshang Mohammad, et al.. (2010). Seroprevalence of Hepatitis D Virus and its Risk Factors in the West of Iran. Journal of Microbiology Immunology and Infection. 43(6). 519–523. 22 indexed citations
14.
Hashemi, Seyyed Hamid, et al.. (2009). Seroprevalence of Immunoglobulin G antibodies against pertussis toxin among asymptomatic medical students in the west of Iran: a cross sectional study. BMC Infectious Diseases. 9(1). 58–58. 21 indexed citations
15.
Keyvani, Hossein, et al.. (2007). Distribution frequency of hepatitis C virus genotypes in 2231 patients in Iran. Hepatology Research. 37(2). 101–103. 58 indexed citations
16.
Fallahian, Farahnaz, Seyed Moayed Alavian, Mitra Ranjbar, et al.. (2007). Insulin resistance in chronic hepatitis B and C.. PubMed. 25(6). 286–9. 19 indexed citations
17.
Hashemi, Seyyed Hamid, et al.. (2007). Osteoarticular complications of brucellosis in Hamedan, an endemic area in the west of Iran. International Journal of Infectious Diseases. 11(6). 496–500. 75 indexed citations
18.
Ranjbar, Mitra, et al.. (2006). Comparison between doxycycline–rifampin–amikacin and doxycycline–rifampin regimens in the treatment of brucellosis. International Journal of Infectious Diseases. 11(2). 152–156. 36 indexed citations
19.
Ranjbar, Mitra. (2006). Polymorphisms of interleukin-1R receptor antagonist genes in patients with chronic hepatitis B in Iran. World Journal of Gastroenterology. 12(31). 5044–5044. 4 indexed citations
20.
Adibi, Peyman, Seyed Moayed Alavian, Mitra Ranjbar, et al.. (2004). Effectiveness of hepatitis B vaccination in children of chronic hepatitis B mothers.. PubMed. 25(10). 1414–8. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenan Hızel Breakdown of academic impact, for papers by Nurgül Ceran Breakdown of academic impact, for papers by Ferhat Arslan Breakdown of academic impact, for papers by Carlos Fritzsche Breakdown of academic impact, for papers by Canan Külah Breakdown of academic impact, for papers by Shariq Haider Breakdown of academic impact, for papers by Can Polat Eyigün Breakdown of academic impact, for papers by Gülsüm İclal Bayhan Breakdown of academic impact, for papers by Rungmei S. K. Marak Breakdown of academic impact, for papers by Robert E. Levitz
Rankless by CCL
2026